Indenture Agreements in the Biotechnology Industry

232 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Supplemental Indenture, dated March 11, 2022, between the Company and U.S. Bank Trust Company, National Association, as Trustee (including the form of 2.25% Convertible...
Indenture Agreements
Retrophin, Inc.
Biotechnology
DE
2022
Indenture dated as of December 17, 2024, between Esperion Therapeutics, Inc. and U.S. Bank Trust Company, National Association, as Trustee
Indenture Agreements
Esperion Therapeutics, Inc.
Biotechnology
DE
2024
Tenth Supplemental Indenture, dated as of November 20, 2024, between the Company and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National...
Indenture Agreements
Gilead Sciences
Biotechnology
NY
2024
Fifth Amendment of Indenture of Lease for Premises Located in Portland, Maine between the Company and TVP, LLC dated as of September 20, 2024
Indenture Agreements
IMMUCELL CORP
Biotechnology
2024
First Supplemental Indenture, dated as of August 30, 2024, by and among Emergent BioSolutions Inc., the subsidiary guarantors party thereto and U.S. Bank Trust Company, National...
Indenture Agreements
Emergent BioSolutions Inc.
Biotechnology
NY
2024
A&R Indenture, dated August 15, 2024, between the Company and GLAS Trust Company LLC, as trustee and collateral agent
Indenture Agreements
PROGENITY, INC.
Biotechnology
NY
2024
First Supplemental Indenture, dated as of August 1, 2024, between Cerevel Therapeutics Holdings, Inc. and U.S. Bank Trust Company, National Association, as trustee
Indenture Agreements
ARYA Sciences Acquisition Corp II
Biotechnology
2024
Fourth Amendment of Indenture of Lease for Premises Located in Portland, Maine between the Company and TVP, LLC dated as of June 11, 2024
Indenture Agreements
IMMUCELL CORP
Biotechnology
2024
Fifth Supplemental Indenture, dated April 17, 2024, between the Company and U.S. Bank National Association, as Trustee (including the form of 1.75% Convertible Senior Notes due...
Indenture Agreements
EXACT SCIENCES CORP
Biotechnology
DE
2024
Second Supplemental Indenture, dated as of March 12, 2024, between Biora Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee
Indenture Agreements
PROGENITY, INC.
Biotechnology
NY
2024
First Supplemental Indenture, dated as of December 19, 2023, between Biora Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee
Indenture Agreements
PROGENITY, INC.
Biotechnology
NY
2024
Indenture, dated as of March 12, 2024, by and between the Company and U.S. Bank Trust Company, National Association, as Trustee
Indenture Agreements
Avid Bioservices, Inc.
Biotechnology
DE
2024
Form of Supplemental Indenture, to be dated as of the Closing Date, between the Company, the guarantors party thereto and GLAS Trust Company LLC
Indenture Agreements
PROGENITY, INC.
Biotechnology
NY
2024
Supplemental Indenture No. 10, dated February 26, 2024, between AbbVie Inc. and U.S. Bank Trust Company, National Association, as trustee
Indenture Agreements
AbbVie Inc.
Biotechnology
NY
2024
Indenture, dated January 9, 2024, by and between OPKO Health, Inc. and U.S. Bank Trust Company, National Association, as Trustee
Indenture Agreements
Opko Health, Inc.
Biotechnology
DE
2024
Indenture, to be dated as of the Closing Date, between the Company and GLAS Trust Company LLC
Indenture Agreements
PROGENITY, INC.
Biotechnology
NY
2023
Third Amendment of Indenture of Lease for Premises Located in Portland, Maine between the Company and TVP, LLC dated as of November 14, 2023
Indenture Agreements
IMMUCELL CORP
Biotechnology
2023
Second Supplemental Indenture, dated as of November 8, 2023, between Intercept Pharmaceuticals, Inc. and U.S. Bank Trust Company, National Association
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2023
Third Supplemental Indenture, dated as of November 8, 2023, between Intercept Pharmaceuticals, Inc., and U.S. Bank Trust Company, National Association
Indenture Agreements
INTERCEPT PHARMACEUTICALS, INC.
Biotechnology
NY
2023
Ninth Supplemental Indenture, dated as of September 14, 2023, between the Company and Computershare Trust Company, National Association, as successor to Wells Fargo Bank, National...
Indenture Agreements
Gilead Sciences
Biotechnology
NY
2023
First Supplemental Indenture, dated August 22, 2023, among Invitae Corporation, the guarantor parties thereto and U.S. Bank Trust Company, National Association, as trustee and...
Indenture Agreements
Invitae Corp
Biotechnology
NY
2023
Indenture, dated as of June 12, 2023, by and between the Company and U.S. Bank Trust Company, National Association, as Trustee
Indenture Agreements
IONIS PHARMACEUTICALS INC
Biotechnology
DE
2023
Indenture, dated as of April 17, 2023, between Mirum Pharmaceuticals, Inc. and U.S. Bank Trust Company, National Association, as trustee
Indenture Agreements
Mirum Pharmaceuticals, Inc.
Biotechnology
DE
2023
Indenture, dated as of March 7, 2023, between Invitae Corporation, the guarantor parties thereto and U.S. Bank Trust Company, National Association, as trustee and collateral agent
Indenture Agreements
Invitae Corp
Biotechnology
NY
2023
Form of New Notes Indenture
Indenture Agreements
Invitae Corp
Biotechnology
NY
2023
Fourth Supplemental Indenture, dated March 1, 2023, between the Company and U.S. Bank National Association, as Trustee (including the form of 2.00% Convertible Senior Notes due...
Indenture Agreements
EXACT SCIENCES CORP
Biotechnology
DE
2023
Indenture, dated as of December 20, 2022, between Novavax, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee
Indenture Agreements
NOVAVAX INC
Biotechnology
NY
2022
Indenture, dated as of September 15, 2022, between the Registrant
Indenture Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2022
First Supplemental Indenture, dated as of October 5, 2022, between Global Blood Therapeutics, Inc. and U.S. Bank Trust Company, National Association, as trustee
Indenture Agreements
Global Blood Therapeutics, Inc.
Biotechnology
2022
Indenture, dated as of September 16, 2022, by and between Sarepta Therapeutics, Inc. and U. S. Bank Trust Company, National Association (including the form of the 1.250%...
Indenture Agreements
Sarepta Therapeutics, Inc.
Biotechnology
DE
2022
Indenture, dated as of September 15, 2022, between Alnylam Pharmaceuticals, Inc. and The Bank of New York Mellon, as trustee
Indenture Agreements
ALNYLAM PHARMACEUTICALS, INC.
Biotechnology
NY
2022
Indenture, dated August 18, 2022 between Halozyme Therapeutics, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee
Indenture Agreements
HALOZYME THERAPEUTICS INC
Biotechnology
NY
2022
Indenture, dated as of August 16, 2022, between Cerevel Therapeutics Holdings, Inc. and U.S. Bank Trust Company, National Association, as trustee
Indenture Agreements
ARYA Sciences Acquisition Corp II
Biotechnology
DE
2022
Second Supplemental Indenture, dated August 15, 2022, by and between Radius Health, Inc. and Wilmington Trust, National Association, as trustee
Indenture Agreements
Radius Health, Inc.
Biotechnology
NY
2022
Indenture, dated as of July 6, 2022, between Cytokinetics, Incorporated and U.S. Bank Trust Company, National Association, as trustee
Indenture Agreements
Cytokinetics, Incorporated
Biotechnology
DE
2022
Consent Under and Amendment No. 4 to Indenture, dated June 3, 2022, by and among Sorrento Therapeutics, Inc., Scilex Pharmaceuticals Inc., U.S. Bank Trust Company, National...
Indenture Agreements
Sorrento Therapeutics, Inc.
Biotechnology
NY
2022
Amendment No. 3 to Indenture of Lease, between Massachusetts Institute of Technology and Beam Therapeutics Inc., dated August 24, 2021
Indenture Agreements
Beam Therapeutics Inc.
Biotechnology
2022
Amendment No. 2 to Indenture of Lease, between Massachusetts Institute of Technology and Beam Therapeutics Inc., dated November 17, 2020
Indenture Agreements
Beam Therapeutics Inc.
Biotechnology
2022
Amendment No. 1 to Indenture of Lease, between Massachusetts Institute of Technology and Beam Therapeutics Inc., dated April 14, 2020
Indenture Agreements
Beam Therapeutics Inc.
Biotechnology
2022
First Supplemental Indenture, dated as of December 22, 2021, by and between the Company and U.S. Bank National Association, as Trustee
Indenture Agreements
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2022